FDA Clearance Tracker · K191313
Unity Subcutaneous Infusion System for Remodulin
Last checked: Nov 20, 2026Latest source record: Feb 21, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Feb 21, 2020
Substantially Equivalent
Time to decision
282 days
Received May 15, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K191313
- Device name
- Unity Subcutaneous Infusion System for Remodulin
- Applicant
- DEKA Research & Development
- Applicant location
- Manchester, NH
- Received
- May 15, 2019
- Decided
- Feb 21, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 880.5725
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QJY (Infusion Pump, Drug Specific, Pharmacy-Filled).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191313
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for DEKA Research & Development
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- twiist system510(k)
K250930 · Decided Apr 2, 2025 · 5 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
K250357 · Decided Mar 11, 2025 · 32 days after receipt
Device type: Pump, Infusion (FRN) · Hospital Medicine & Nursing
- Remunity System510(k)
K243354 · Decided Nov 27, 2024 · 29 days after receipt
Device type: Infusion Pump, Drug Specific, Pharmacy-Filled (QJY) · Hospital Medicine & Nursing
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.